Totally Ansoff Matrix

Totally Ansoff Matrix

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Totally Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Explore the Complete Growth Strategy Behind the Preview

This Totally Ansoff Matrix Analysis gives a clear, company-specific view of Totally's growth options across market penetration, market development, product development, and diversification. What you see on this page is a real preview of the actual analysis, not just marketing text, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.

Market Penetration

Icon

Securing five-year extensions on existing NHS Urgent Care contracts

Totally's market penetration strategy is to secure five-year extensions on existing NHS Urgent Care contracts, targeting a 95% retention rate through 2026. With 50 current centers, long contract visibility supports scale benefits, steadier cost absorption, and deeper ties with Integrated Care Boards. Reliable clinical delivery across these sites keeps Totally positioned as a core partner for high-volume NHS demand.

Icon

Improving clinician utilization rates through proprietary scheduling technology

Totally is using proprietary scheduling software to lift practitioner productivity by about 12%, so its existing clinicians can see more patients each day. In a market where NHS waits still affect demand, better rota planning helps the Company use its diagnostic and urgent care sites harder without adding new rooms or higher base overhead. That supports market penetration by growing volume from the current footprint, not from new sites. Each extra slot improves revenue capacity from the same fixed asset base.

Explore a Preview
Icon

Expanding volume for elective care insourcing services across 20 hospital trusts

This market penetration move expands Company Name elective care insourcing across 20 hospital trusts, capturing a larger share of the regional surgical backlog. By placing specialist clinical teams inside existing public hospitals, Company Name can help deliver about 1,500 extra procedures each month and keep underused theatres busy. That makes Company Name a preferred vendor for fast waitlist reduction programmes.

Icon

Consolidating specialist health brands to build a unified clinical presence

By consolidating specialist health brands under one clinical identity, the business strengthens market penetration in its existing regions and makes its service easier to recognize and trust. A single pathway from digital referral to specialist diagnosis reduces friction, which can lift self-funding clinic demand and improve conversion from first contact to booked care. In a market where older patients drive much of specialist health use, clearer branding also widens awareness and builds a harder-to-copy local moat.

Icon

Capturing a 15 percent increase in volume through regional GP out-of-hours contracts

Totally's market penetration play is to win more regional GP out-of-hours contracts and lift volume by 15% in established urban and rural areas. By combining 24-hour clinical cover with telehealth, it can beat smaller local providers that often lack scale, staffing depth, and digital reach.

This is a classic Ansoff move: grow the core service in the same market, not a new one. Higher contract volume should also spread fixed infrastructure and tech costs across more visits, which can improve recurring revenue quality in FY2025.

Icon

Totally Targets 95% Retention and 12% Productivity Lift in FY2025

Totally's FY2025 market penetration focus is to deepen share in existing NHS and elective care channels, not enter new ones. It targets 95% contract retention across 50 centers, using scheduling software to lift productivity about 12% and expand output from the same base. Its insourcing work across 20 hospital trusts adds about 1,500 procedures a month, while GP out-of-hours volume targets imply 15% growth in core markets.

FY2025 lever Data
Centers 50
Retention target 95%
Productivity lift 12%
Hospital trusts 20
Extra procedures 1,500/month
Volume target 15%

What is included in the product

Word Icon Detailed Word Document
Outlines Totally's growth strategy across existing and new products and markets through the Ansoff Matrix framework
Plus Icon
Excel Icon Editable Excel File
Simplifies growth planning with a clear Ansoff matrix that quickly spots expansion priorities.

Market Development

Icon

Establishing new elective care operations in the Republic of Ireland

Totally is moving into the Republic of Ireland's public healthcare market with its outpatient surgery and clinic management model. By early 2026, it expects at least 3 service agreements with the Health Service Executive for local diagnostic care, turning UK operating know-how into a new revenue line. The move targets a system serving about 5.4 million people and fits a market development play.

Icon

Deploying mobile health screening units into high-density industrial centers

Deploying mobile health screening units into high-density industrial centers gives Totally a new physical route to market for its existing diagnostic tests. Instead of asking thousands of employees at one manufacturing site to travel to community offices, the Company brings screenings and wellness checks to the job site, cutting lost work time and widening access. This market development move can lift test volume fast because one campus can funnel a large, captive workforce through the same on-site channel.

Explore a Preview
Icon

Marketing corporate physiotherapy programs to multinational firms with UK offices

Marketing corporate physiotherapy to UK multinationals turns Totally's occupational health and physical therapy into a premium employee benefit, aimed at firms with 1,000+ staff. This lifts the addressable market beyond the public sector and targets higher-margin buyers that can fund on-site care, triage, and fast return-to-work support. It also scales with the clinical team already in place, so growth comes from selling more into the same service base, not adding a new delivery model.

Icon

Entering 10 new Northern UK Trusts with virtual ward management services

Entering 10 new Northern UK Trusts fits market development: the same virtual ward model is sold into a new region where acute bed pressure stays high. After a 20% cut in readmissions in Southern markets, Company Name has a live proof point for NHS buyers, while remote monitoring needs far less local capex than a new clinic. That lets Company Name scale faster across trusts, with lower fixed costs and quicker payback.

Icon

Opening urban health hubs within major metropolitan transport centers

This Market Development move puts Totally in central railway and transit hubs, where London's transport network serves millions of daily journeys and commuter demand is highest. By placing walk-in diagnostics and primary care in station sites, Company Name shifts from residential catchments to fast, high-traffic business districts, aiming to win time-sensitive patients who want care without booking delays.

The first 5 London locations will act as a live test of adoption, visit volumes, and unit economics before any rollout to other city hubs.

Icon

Totally Expands Into Ireland, Northern UK Trusts, and London Hubs

Totally's market development push uses existing care models in new buyer pools: Ireland's HSE, 10 Northern UK Trusts, and London rail hubs. The signal is simple: the same service, new geography, with proof points like a 20% readmission cut and a 5.4 million-person Irish public system.

Move 2025-26 signal
Ireland 3 HSE agreements
Northern Trusts 10 target trusts
London hubs First 5 sites

Preview Before You Purchase
Totally Reference Sources

This is the actual Totally Ansoff Matrix Analysis document you'll receive after purchase-no surprises, just the full professional version. The preview below is taken directly from the complete report, so what you see is exactly what you'll get. Once purchased, the full analysis is unlocked immediately for download.

Explore a Preview

Product Development

Icon

Integrating AI-driven clinical triage to reduce patient wait times

Totally's AI-driven clinical triage fits Product Development by adding a new capability to its existing service suite. The machine learning tools help call handlers judge patient priority more accurately and cut initial diagnostic call time by about 18%, improving flow and lowering wait times. This matters most for high-risk patients, where faster triage can improve safety and care quality.

Icon

Launching a personalized digital portal for post-operative orthopedic recovery

In Ansoff Matrix terms, this is Product Development: the firm is adding a new digital service for current orthopedic patients. The mobile app gives surgical patients a 12-week rehab plan, mobility tracking, and video access to therapists, which can trim repeat follow-up visits. Telehealth use stays well above pre-2020 levels in 2025, so tech-savvy patients are likely to welcome this shift.

Explore a Preview
Icon

Expanding the clinical portfolio with comprehensive menopause health assessments

The organization's menopause screening package is a product development move that fits a maturing female workforce, where menopause affects about 1 billion women globally and symptoms hit up to 75% of them. Corporate buyers are likely to see it as a retention tool, since UK data show menopause-related work losses can cost employers about £1.8 billion a year. This keeps the service aligned with current clinical demand and workplace health trends.

Icon

Implementing a premium 48-hour diagnostic testing service tier

By adding a premium 48-hour tier for complex blood panels and imaging, Company Name moves into market penetration plus product development: the same core lab assets now serve speed-sensitive patients who will pay more for faster results.

This is attractive because it layers a higher-price service over existing infrastructure, so incremental clinical cost stays low while gross margin can rise.

In 2025, faster diagnostics is still a clear gap in private care, especially for self-pay and employer-paid patients who value a 2-day turnaround.

Icon

Adding remote cardiac monitoring to existing homecare patient services

Totally's product development move adds remote cardiac monitoring to its homecare offer, using wearable devices for post-surgery patients who need close heart checks. The same central clinical teams can track 24-hour vital signs, so the firm builds a higher-value service without a full new care network. It also deepens chronic disease management with a preventive layer that can lower readmissions and lift service revenue per patient.

Icon

Totally Bets on Faster Digital Care to Boost Access and Revenue

Totally's Product Development in 2025 adds new digital care to an existing patient base: AI triage, rehab app, menopause screening, premium 48-hour diagnostics, and remote cardiac monitoring. The clearest value is faster access and better care flow, with triage time down 18% and telehealth still above pre-2020 levels.

These offers also raise revenue per patient without rebuilding the care network. Menopause affects about 1 billion women globally, and up to 75% have symptoms, so the screening package fits a large unmet need.

Move 2025 signal
AI triage 18% faster calls
Menopause screen 1B women; 75% symptomatic
48-hour diagnostics Higher-margin speed tier

Diversification

Icon

Managing medical infrastructure for private senior living community developers

Totally's move into senior living is diversification: it takes clinical monitoring skills and applies them to a new market, residential elder care. By managing safety sensors and automated health systems across 10 regional villages, it supports developers building high-tech retirement sites for a fast-growing 65+ market, which the UN says will reach about 1.1 billion people in 2025. The upside is new revenue from a long-stay property base, but success depends on reliable uptime and compliance.

Icon

Entering the direct-to-consumer market with home biometric testing kits

Entering direct-to-consumer home biometric testing kits diversifies Company Name from a service model into retail health products sold on e-commerce channels.

Each kit can screen key markers at home and deliver results through Company Name's cloud platform, which can lift gross margins and create repeat revenue from refill kits, subscriptions, and follow-up tests.

This move fits Ansoff's diversification quadrant because it adds a new product and a new market at the same time, but it also raises execution risk in regulation, logistics, and consumer trust.

Explore a Preview
Icon

Creating a standalone professional medical education and certification division

Totally is diversifying with a standalone professional medical education and certification division, adding a new revenue stream beyond clinical services. The subsidiary targets 600 healthcare practitioners in its first 18 months across the UK and Ireland, with accredited urgent care training designed to meet workforce demand as the UK NHS employed about 1.7 million people in 2025. This move should also deepen Totally's reputation for medical expertise and leadership.

Icon

Acquiring a health data analytics firm to develop proprietary insights

The company's acquisition of a specialist medical data firm adds a new health-intelligence consulting arm, moving it into data services. That lets it sell clinical trend insights to pharmaceutical firms and government researchers, not just patient-facing care. By monetizing internal data sets, it diversifies revenue into higher-margin B2B analytics and lowers reliance on service fees.

Icon

Developing luxury medical wellness resorts for high-net-worth individual patients

This diversification pushes Company Name into luxury medical wellness, where the global wellness economy was about $6.3 trillion in 2023 and is projected to keep rising fast. By pairing five-star hospitality with clinical oversight, 7-14 day residency programs, and proactive longevity and weight-loss care, it targets high-net-worth patients who want measurable outcomes, not just a spa stay. That makes Company Name less tied to illness care and more exposed to a higher-margin, fast-growing niche.

Icon

Totally's Big Bet: Diversifying Into High-Growth Health Markets

Totally's diversification moves pair new products with new markets: senior living tech, home biometric kits, medical education, data analytics, and luxury wellness. That spreads revenue beyond core care services, but it also raises regulatory, logistics, and delivery risk. The 65+ population is about 1.1 billion in 2025, and the UK NHS employs about 1.7 million people.

Move Why it fits
Senior living tech New market
Biometric kits New product
Medical data B2B analytics

Frequently Asked Questions

Totally Business prioritizes securing 5-year contract extensions at 50 different healthcare hubs to ensure revenue stability. By boosting internal operational efficiency by 15 percent, they increase throughput within existing clinic centers. This tactical focus helps the NHS manage 111 service volumes while defending the company's core market share throughout fiscal 2026 and beyond.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.